Source comparison
Mechanism of Action: How Follistatin-344 vs MK-677 Work at the Molecular Level
Follistatin-344 is a glycoprotein that binds with high affinity to members of the TGF-beta superfamily, particularly myostatin (GDF-8) and activin. Myostatin circulates systemically and binds to activin type II receptors on muscle satellite cells, triggering S
This comparison does not assign a generated winner or score.
- Follistatin-344 is a glycoprotein that binds with high affinity to members of the TGF-beta superfamily, particularly myostatin (GDF-8) and activin. Myostatin circulates systemically and binds to activin type II receptors on muscle satellite cells, triggering SMAD2/3 phosphorylation. The signaling cascade that suppresses myoblast proliferation and differentiation. When follistatin-344 binds to myostatin before it reaches the receptor, that inhibitory signal never reaches the nucleus. The result is increased satellite cell activation potential and reduced catabolic signaling in mature muscle fibers. This mechanism is why follistatin-344 research focuses on conditions where muscle growth is pathologically restricted. The compound doesn't create growth, it removes molecular inhibition.
- The half-life of follistatin-344 in circulation is approximately 3–4 hours, requiring frequent dosing in research protocols that maintain therapeutic concentrations. Because follistatin is a binding protein rather than a receptor agonist, its activity depends on the presence of target ligands. If myostatin or activin levels are low, follistatin's observable effect diminishes proportionally. This context-dependent activity is critical when comparing follistatin-344 vs MK-677 in study design.
- MK-677 functions as a selective agonist of the ghrelin receptor (growth hormone secretagogue receptor, GHSR-1a), located primarily in the hypothalamus and pituitary gland. Activation of GHSR-1a stimulates somatotroph cells in the anterior pituitary to release growth hormone in a pulsatile pattern that mimics endogenous secretion. Elevated growth hormone then stimulates hepatic IGF-1 production. The primary mediator of growth hormone's anabolic effects. MK-677 has a half-life of approximately 24 hours, making once-daily administration sufficient to maintain receptor occupancy throughout a research cycle.
- The key mechanistic distinction when evaluating follistatin-344 vs MK-677: follistatin operates downstream at the tissue level, blocking inhibitory signals that would otherwise suppress muscle protein synthesis. MK-677 operates upstream in the endocrine axis, amplifying the hormonal environment that supports anabolism across multiple tissues. One removes a brake; the other increases the accelerator input. In our experience supplying research peptides, protocols that conflate these mechanisms consistently produce confounded results. The compounds aren't interchangeable alternatives, they're interventions at opposite ends of the growth regulation system.